A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
Lyell Immunopharma, Inc.
Yale University
Genmab
St. Jude Children's Research Hospital
Gilead Sciences
Affiliated Hospital to Academy of Military Medical Sciences
Novartis
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Gilead Sciences
Allogene Therapeutics
Allogene Therapeutics
Allogene Therapeutics
Regeneron Pharmaceuticals
Gilead Sciences
St. Jude Children's Research Hospital
Baylor College of Medicine
Celgene
Chinese PLA General Hospital
Princess Maxima Center for Pediatric Oncology
Princess Maxima Center for Pediatric Oncology
Princess Maxima Center for Pediatric Oncology
University of Maryland, Baltimore
Affimed GmbH
Chinese PLA General Hospital
Dana-Farber Cancer Institute
University Health Network, Toronto
City of Hope Medical Center
CARGO Therapeutics
Thomas Jefferson University
City of Hope Medical Center
Affiliated Hospital to Academy of Military Medical Sciences
Genmab
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd
M.D. Anderson Cancer Center
Gilead Sciences
Sunnybrook Health Sciences Centre
Memorial Sloan Kettering Cancer Center
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd
Chinese PLA General Hospital
Therapeutic Advances in Childhood Leukemia Consortium
University College, London
The First Affiliated Hospital of Soochow University
Shanghai Ming Ju Biotechnology Co., Ltd.
Precision BioSciences, Inc.
Gilead Sciences
Roswell Park Cancer Institute
Therapeutic Advances in Childhood Leukemia Consortium
Masonic Cancer Center, University of Minnesota
Therapeutic Advances in Childhood Leukemia Consortium